So far Dr K's target is a long way off....even if he ups it to $15 or $20 I think $10 is a good target given the current PPS.

By the EOY we should have a really good idea if BETonMACE is going to lead to drug approval....which in turn should mean actual revenue obviously.  Then in the months and years to come after that we'll find out about all the other potential indications, CKD, Fabry's, Musc Dyst, Dengerative Retinal, HIV, Alzheimers and all the rest.....

Maybe in 2 or 3 years, if Resverlogix takes this not just to the finish line but beyond....maybe we'll be looking at $100's of dollars with the chance to find out what other drugs they can develop out of that Epigenetic blood bank Don loves to talk about.

CDMO's mean Resverlogix doesn't have to produce the actual drugs themselves....owning the patent is what's important.